Relationship between interferon-γ, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-α

Journal of Clinical Immunology

Volumn 20, Issue 1, 2000, Pages 54-61

  Piazzolla, Giuseppina ^a,b   Tortorella, Cosimo ^a   Schiraldi, Oronzo ^a   Antonaci, Salvatore ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Chronic hepatitis C; IFN ; IL 10; IL 12 p40; IL 12 p70

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; NEUTRALIZING ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; CELLS, CULTURED; CYTOKINES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN;

EID: 0034087136     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006694627907     Document Type: Article

References (43)

1. 1. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675, 1990
2. 2. Chisari FV: Cytotoxic T cells and viral hepatitis. J Clin Invest 99:1472-1477, 1997
3. 3. Antonaci S, Schiraldi S: Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: Defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A review. Immunopharmacol Immunotoxicol 20:455-472, 1998
4. 4. Koziel MJ, Dudley D, Afdhal N, Grakoni A, Rice CM, Choo QL, Houghton M, Walker BD: HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96:2311-2321, 1995
5. 5. Romagnani S: Lymphokine production by human T cells in disease state. Annu Rev Immunol 12:227-257, 1994
6. 6. Tsai SL, Chen PJ, Hwang LH, Kao JH, Huang JH, Chang TH, Chen DS: Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection. J Hepatol 21:403-411, 1994
7. 7. Mosmann TR, Coffman RL: Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 46:111-147, 1989
8. 8. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787-793, 1996
9. 9. Del Prete G, Maggi E, Romagnani S: Human Th1 and Th2 cells: Functional properties, mechanisms of regulation and role in disease. Lab Invest 70:299-306, 1994
10. 10. Street NE, Schumacher JH, Fong TA, Bass H, Fiorentino DF, Leverah JA, Mosmann TR: Heterogeneity of mouse helper T cells: Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 144:1629-1639, 1990
11. 11. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
12. 12. Tanaka T, Hu-Li J, Seder RA, De Fazekas S, Groth B, Paul WE: Interleukin-4 suppresses interleukin-2 and interferon-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA 90:5914-5918, 1993
13. +T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition in such priming. Proc Natl Acad Sci USA 90:10,188-10,192, 1993
14. 14. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170:827-845, 1989
15. 15. Stern AS, Podlaski FJ, Hulmes JD, Pan YC, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK: Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87:6808-6812, 1990
16. 16. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Niekbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (Interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398, 1992
17. 17. Trinchieri G: Interleukin 12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008-4027, 1994
18. 18. Gately MK, Mulqueen MJ: Interleukin 12: potential clinical applications in the treatment and prevention of infectious diseases. Drugs 52(Suppl 2): 18-26, 1996
19. 19. Osna N, Silonova G, Vilgert N, Hagina E, Kuse V, Giedraitis V, Zvirbliene A, Mauricas M, Sochnev A: Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood. Scand J Clin Lab Invest 57:703-710, 1997
20. 20. Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M, Yoshioka K: Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 108:138-143, 1997
21. 21. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21(Suppl):77-89, 1968
22. 22. Yam LT, Li CY, Crosby MH: Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283-290, 1971
23. 23. Murray HW: Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med 108: 595-608, 1988
24. 24. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM: Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre-and posttreatment with interferon alfa. Hepatology 24:6-9, 1996
25. 25. Iwata K, Wakita T, Okumura A, Yoshioka K, Takayanagi M, Wands JR, Kakumu S: Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 22:1057-1064, 1995
26. 26. Bansal AS, Bruce J, Hogan PG, Prichard P, Powell EE: Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-γ is elevated in patients with hepatitis C infection. Clin Immunol Immunop 84: 139-144, 1997
27. 27. Lohr HF, Schlaak JH, Gerken G, Fleischer B, Dienes HP, Moyer zum Buschenfelde KH: Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T-lymphocytes from patients with chronic hepatitis of different etiology. Liver 14:161-166, 1994
28. 28. Jirillo E, Greco B, Caradonna L, Satalino R, Pugliese V, Cozzolongo R, Cuppone R, Manghisi OG: Evaluation of cellular immune response and soluble mediators in patients with chronic hepatitis C (cHCV) infection. Immunopharmacol Immunotoxicol 17:347-364, 1995
29. 29. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC: Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25:449-458, 1997
30. 30. Clerici M, Shearer GM. A: TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107-111, 1993
31. 31. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279, 1992
32. 32. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 10:385-409, 1992
33. 33. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041-1048, 1993
34. 34. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M: IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158:1541-1550, 1997
35. 35. Hunter CA, Bermudez L, Beernink H, Waegell W, Remington JS: Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur J Immunol 25:994-1000, 1995
36. 36. Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H: Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 13:680-684, 1998
37. 37. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154:116-127, 1995
38. 38. Heinzel FP, Hujer AM, Ahmed FN, Rerko RM: In vivo production and function of IL-12 p40 homodimers. J Immunol 158:4381-4388, 1997
39. 39. Von Grunberg PW, Plum G: Enhanced induction of interleukin-12 (p40) secretion by human macrophages infected with Mycobacterium avium complex isolates from disseminated infection in AIDS patients. J Infect Dis 178:1209-1212, 1998
40. 40. Naoumov NV, Rossol S: Studies of interleukin-12 in chronic hepatitis B virus infection. J Viral Hepat 4(Suppl 2):87-91, 1997
41. 41. Cousens LP, Orange JS, Su HC, Biron CA: Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA 94:634-639, 1997
42. 42. McRae BL, Semnani RT, Hayes MP, van Seventer GA: Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 160:4298-4304, 1998
43. 43. Hermann P, Rubio M, Nakajima T, Delespesse G, Sarfati M: IFN-α priming of human monocytes differentially regulates Gram-positive and Gram-negative bacteria-induced IL-10 release and selectively enhances IL-12 p70, CD80, and MHC class I expression. J Immunol 161:2011-2018, 1998